









市场行情
/
股票
/
nasdaq-ecor
/

electroCore, Inc.

ECOR

4.600USD

+0.180+4.07%

收盘 12/19, 16:00（美东）报价延迟15分钟

35.12M总市值

亏损市盈率 TTM



electroCore, Inc.

4.600

+0.180+4.07%

概览公司财务分析

概览

公司

财务

分析

关于 electroCore, Inc. 公司

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

electroCore, Inc.简介



公司代码ECOR

公司名称electroCore, Inc.

上市日期Jun 22, 2018

CEOGoldberger (Daniel S)

员工数量73

证券类型Ordinary Share

年结日Jun 22

公司地址200 Forge Way

城市ROCKAWAY

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编07866

电话19732900097

网址https://www.electrocore.com/

公司代码ECOR

上市日期Jun 22, 2018

CEOGoldberger (Daniel S)

electroCore, Inc.公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Daniel S. (Dan) Goldberger

Chief Executive Officer, Director

185.90K

+0.54%

Mr. Thomas M. (Tom) Patton, J.D.

Independent Director

102.78K

+22.69%

Mr. John P. Gandolfo

Independent Director

88.10K

+27.52%

Ms. Patricia Wilber

Independent Director

72.33K

+35.66%

Ms. Elena Bonfiglioli

Director

30.55K

Dr. Thomas J. Errico, M.D.

Independent Chairman of the Board

Mr. Joshua S. Lev

Chief Financial Officer

Ms. Julie A. Goldstein

Independent Director

Mr. James C. Theofilos

Director

名称

名称/职务

职务

持股

持股变动

Mr. Daniel S. (Dan) Goldberger

Chief Executive Officer, Director

185.90K

+0.54%

Mr. Thomas M. (Tom) Patton, J.D.

Independent Director

102.78K

+22.69%

Mr. John P. Gandolfo

Independent Director

88.10K

+27.52%

Ms. Patricia Wilber

Independent Director

72.33K

+35.66%

Ms. Elena Bonfiglioli

Director

30.55K

Dr. Thomas J. Errico, M.D.

Independent Chairman of the Board

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Rx gammaCore - Department of Veteran Affairs and Department of Defense

5.18M

70.25%

Truvaga

994.00K

13.47%

Outside the United States

465.00K

6.30%

Rx gammaCore - U.S. Commercial

394.00K

5.34%

TAC-STIM

181.00K

2.45%

其他

162.00K

2.19%

地区USD

名称

营收

占比

United States

6.89M

93.42%

United Kingdom

433.00K

5.87%

Other

36.00K

0.49%

Japan

17.00K

0.23%

业务

地区

业务USD

名称

营收

占比

Rx gammaCore - Department of Veteran Affairs and Department of Defense

5.18M

70.25%

Truvaga

994.00K

13.47%

Outside the United States

465.00K

6.30%

Rx gammaCore - U.S. Commercial

394.00K

5.34%

TAC-STIM

181.00K

2.45%

其他

162.00K

2.19%

股东统计

更新时间: 11月18日周二

持股股东

股东类型

持股股东

占比

Zhang (Tianyi)

9.19%

Theofilos (Charles Steve)

5.56%

Hilve Holdings Ltd

5.40%

Errico (Thomas J.)

3.83%

The Vanguard Group, Inc.

2.92%

其他

73.10%

持股股东

占比

Zhang (Tianyi)

9.19%

Theofilos (Charles Steve)

5.56%

Hilve Holdings Ltd

5.40%

Errico (Thomas J.)

3.83%

The Vanguard Group, Inc.

2.92%

其他

73.10%

股东类型

持股股东

占比

Individual Investor

26.93%

Corporation

8.76%

Investment Advisor

6.05%

Hedge Fund

1.57%

Investment Advisor/Hedge Fund

1.36%

Research Firm

0.02%

其他

55.31%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

727.72K

16.70%

2025Q3

727.72K

17.61%

-444.98K

2025Q2

1.17M

19.50%

-199.13K

2025Q1

1.37M

13.77%

+380.78K

2024Q4

936.59K

18.00%

-138.83K

2024Q3

1.06M

17.69%

+20.62K

2024Q2

1.04M

19.14%

+51.56K

2024Q1

992.08K

19.07%

-152.78K

2023Q4

961.96K

18.72%

+22.04K

2023Q3

937.71K

13.66%

+316.94K

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Zhang (Tianyi)

734.64K

9.25%

+734.64K

May 15, 2025

Theofilos (Charles Steve)

444.53K

5.6%

Jul 04, 2025

Hilve Holdings Ltd

432.00K

5.44%

+432.00K

Aug 15, 2025

Errico (Thomas J.)

306.38K

3.86%

+26.61K

+9.51%

Sep 02, 2025

The Vanguard Group, Inc.

232.33K

2.92%

Jun 30, 2025

Goldberger (Daniel S)

184.90K

2.33%

+1.00K

+0.54%

Aug 11, 2025

Happy Holstein Management, LLC

153.17K

1.93%

Jul 04, 2025

MAZ Partners, L.P.

115.52K

1.45%

-156.44K

-57.52%

May 13, 2025

Patton (Thomas M)

102.78K

1.29%

+19.01K

+22.69%

Sep 02, 2025

Goldstein (Julie Ann)

101.39K

1.28%

+19.01K

+23.08%

Sep 02, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

iShares Micro-Cap ETF

占比0%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

公告日期

类型

比率

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

常见问题

electroCore, Inc.的前五大股东是谁？



electroCore, Inc. 的前五大股东如下：
Zhang (Tianyi)持有股份：734.64K，占总股份比例：9.25%。
Theofilos (Charles Steve)持有股份：444.53K，占总股份比例：5.60%。
Hilve Holdings Ltd持有股份：432.00K，占总股份比例：5.44%。
Errico (Thomas J.)持有股份：306.38K，占总股份比例：3.86%。
The Vanguard Group, Inc.持有股份：232.33K，占总股份比例：2.92%。